Considering that proliferation and differentiation processes in both AD and Pso are disturbed, and that therapeutic effects of AHR activation are not specific to AD but are also demonstrated in Pso patients [57], efficacy of IMA-compounds in psoriasiform inflammation may be expected. Here, AHR is linked to Alzheimer disease.